Boston Jury Awards Teva Pharmaceuticals $176.5M for Eli Lilly's Migraine Medication Patent Infringement | Law.com
Teva Pharmaceuticals Archives - The Qualitalks Podcast
Teva Pharmaceutical Industries. Information about the issuer. (LEI 549300BAFGM4RC74ZJ94, SWIFT TEVPILITXXX). News and credit ratings. Tables with accounting and financial reports.
Jury finds Teva Pharmaceuticals fueled opioid epidemic in New York State
Why Teva Pharmaceuticals Stock Has Two A-Products In The Bag (NYSE:TEVA) | Seeking Alpha
Teva, one of the biggest generic makers, joins the the brand-name club
Teva Announces Nationwide Opioids Settlement to Move Forward After Receiving Broad Support from States | Business Wire
Teva announces $519 million FCPA settlement | The FCPA Blog
Teva reaches proposed $4.35 billion settlement of US opioid lawsuits | CNN Business
Teva Pharma appoints Novartis, Biogen vet as new president and CEO – PharmaLive
Teva Pharma CEO: We see a stable U.S. market place for our generics - YouTube
Pharmaceutical Company Reaches Settlement With Oklahoma In Opioid Case : NPR